U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8226182261A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells TransplantationEnrolling by invitationNo Results AvailableHereditary Cerebellar Ataxia.Other: stem cell transplantationhttps://ClinicalTrials.gov/show/NCT01489267
8226282262Efficacy and Safety of GTR in Comparison to Copaxone®CompletedNo Results AvailableMultiple SclerosisDrug: Glatiramer Acetate (GTR)|Drug: Glatiramer Acetate (Copaxone®)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01489254
8226382263Short-term Telehealth Follow up After Hospital Discharge for Chronic Obstructive Pulmonary Disease ExacerbationCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveProcedure: Telemonitoringhttps://ClinicalTrials.gov/show/NCT01489241
8226482264Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas DiseaseRecruitingNo Results AvailableChronic Chagas Disease, IndeterminateDrug: E1224|Drug: Benznidazole|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01489228
8226582265Interventions for Sleep Problems in Early ChildhoodNot yet recruitingNo Results AvailableSleep DisorderBehavioral: "presence"|Behavioral: "checking"https://ClinicalTrials.gov/show/NCT01489215
8226682266Effects of DES Platforms on Markers of Endothelial Damage and InflammationNot yet recruitingNo Results AvailableCoronary Artery DiseaseDevice: platinum chromium everolimus-eluting stent|Device: cobalt chromium everolimus-eluting stenthttps://ClinicalTrials.gov/show/NCT01489202
8226782267Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic RetinopathyActive, not recruitingNo Results AvailableProliferative Diabetic RetinopathyOther: Prompt Panretinal Photocoagulation|Drug: 0.5-mg Ranibizumab|Other: Deferred panretinal photocoagulationhttps://ClinicalTrials.gov/show/NCT01489189
8226882268Regadenoson Real Time Perfusion Imaging Trial-OptisonRecruitingNo Results AvailableCoronary Artery Disease|Myocardial Perfusion AbnormalitiesDrug: Regadenoson; Optisonhttps://ClinicalTrials.gov/show/NCT01489176
8226982269Lifestyle Intervention Program for Women With Gestational Diabetes or Gestational Impaired Glucose ToleranceActive, not recruitingNo Results AvailableGestational DiabetesBehavioral: Lifestyle Counselinghttps://ClinicalTrials.gov/show/NCT01489163
8227082270Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory FailureCompletedNo Results AvailableHypercapnic Respiratory Failurehttps://ClinicalTrials.gov/show/NCT01489150
8227182271The EC90 of Remifentanil Blunting Hemodynamic Changes to Head FixationCompletedNo Results AvailableBrain Tumor|AVM|ICHDrug: remifentanilhttps://ClinicalTrials.gov/show/NCT01489137
8227282272The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated PneumoniaCompletedNo Results AvailableVentilator-Associated PneumoniaDrug: Imipenem|Drug: Imipenem|Drug: Imipenemhttps://ClinicalTrials.gov/show/NCT01489124
8227382273Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia ARecruitingNo Results AvailableCongenital Bleeding Disorder|Haemophilia ADrug: turoctocog alfa pegolhttps://ClinicalTrials.gov/show/NCT01489111
8227482274Effect of the Level of Dietary Protein on Body CompositionCompletedNo Results AvailableGrowth Accelerationhttps://ClinicalTrials.gov/show/NCT01489098
8227582275Observational Study Evaluating the Use of Intellivent® for Patients With Respiratory Distress SyndromeCompletedNo Results AvailableRespiratory Distress Syndromehttps://ClinicalTrials.gov/show/NCT01489085
8227682276Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of AnesthesiaCompletedNo Results AvailableCough|AnesthesiaDrug: Remifentanil|Drug: Remifentanilhttps://ClinicalTrials.gov/show/NCT01489072
8227782277Safety Study of IL-21/Ipilimumab Combination in the Treatment of MelanomaCompletedNo Results AvailableMelanomaBiological: BMS-982470 (recombinant interleukin-21)|Biological: BMS-982470 (recombinant interleukin-21)|Biological: BMS-982470 (recombinant interleukin-21)|Biological: BMS-982470 (recombinant interleukin-21)|Biological: Ipilimumab|Biological: Ipilimumab|Biological: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01489059
8227882278Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naiveTerminatedNo Results AvailableHIV-1 InfectionDrug: BMS-986001|Drug: BMS-986001|Drug: BMS-986001|Drug: Placebo matching with BMS-986001|Drug: Efavirenz|Drug: Lamivudine|Drug: Tenofovirhttps://ClinicalTrials.gov/show/NCT01489046
8227982279Subcutaneous Immunotherapy in Patients Sensitized to Phleum PratenseCompletedNo Results AvailableAllergic RhinoconjunctivitisBiological: Subcutaneous immunotherapy with Phleum pratense pollen extracthttps://ClinicalTrials.gov/show/NCT01489033
8228082280Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)CompletedNo Results AvailableAllergic RhinoconjunctivitisBiological: subcutaneous immunotherapy with DPT extracthttps://ClinicalTrials.gov/show/NCT01489020
8228182281Iron Absorption in Vegetarian ChildrenActive, not recruitingNo Results AvailableIron Absorptionhttps://ClinicalTrials.gov/show/NCT01489007
8228282282BAX 326 Pediatric StudyCompletedNo Results AvailableHemophilia BBiological: Recombinant Factor IXhttps://ClinicalTrials.gov/show/NCT01488994
8228382283Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain InjuryTerminatedNo Results AvailableTraumatic Brain InjuryOther: Upper Extremity Therapy without stimulation|Device: Upper Extremity Therapy with stimulation from the Radiofrequency Microstimulator (RFM) System (Alfred Mann Foundation, Santa Clarita, CA)https://ClinicalTrials.gov/show/NCT01488981
8228482284Conventional Versus Hypofractionated Radiation in High Risk Prostate PatientsRecruitingNo Results AvailableHigh-risk Prostate CancerRadiation: Standard Radiation Treatment|Radiation: Hypofractionated radiation treatmenthttps://ClinicalTrials.gov/show/NCT01488968
8228582285Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTICompletedNo Results AvailableUrinary Tract InfectionDrug: Ibuprofen|Drug: Fosfomycin-Trometamolhttps://ClinicalTrials.gov/show/NCT01488955
8228682286Use of Incentives to Retain Drug Users in HIV TherapyRecruitingNo Results AvailableHIV InfectionOther: monetary reinforcerhttps://ClinicalTrials.gov/show/NCT01488942
8228782287Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With SchizophreniaCompletedNo Results AvailableSchizophrenia|Negative Symptoms|Cognitive DysfunctionDrug: TC-5619|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01488929
8228882288Vitamin D Inadequacy on Postprandial Glucose in Type 2 Diabetes MellitusRecruitingNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT01488916
8228982289A Cohort Research of Genetic Susceptibility for Common Obesity in WomenRecruitingNo Results AvailableObesity|Menopausehttps://ClinicalTrials.gov/show/NCT01488903
8229082290Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNo Results AvailableDengue|Dengue Fever|Dengue Hemorrhagic Fever|Yellow FeverBiological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus|Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus|Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus|Biological: Yellow Feverhttps://ClinicalTrials.gov/show/NCT01488890

* Görseller ve İçerik tekif hakkına sahip olabilir